131 related articles for article (PubMed ID: 22079489)
1. Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures.
Bojnik E; Turunç E; Armağan G; Kanıt L; Benyhe S; Yalçın A; Borsodi A
Epilepsy Res; 2012 Mar; 99(1-2):64-8. PubMed ID: 22079489
[TBL] [Abstract][Full Text] [Related]
2. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
3. The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats.
Kozan R; Ayyildiz M; Agar E
Epilepsia; 2009 Jul; 50(7):1760-7. PubMed ID: 19453709
[TBL] [Abstract][Full Text] [Related]
4. Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist.
Amaya F; Shimosato G; Kawasaki Y; Hashimoto S; Tanaka Y; Ji RR; Tanaka M
Pain; 2006 Sep; 124(1-2):175-83. PubMed ID: 16709443
[TBL] [Abstract][Full Text] [Related]
5. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
Wallace MJ; Blair RE; Falenski KW; Martin BR; DeLorenzo RJ
J Pharmacol Exp Ther; 2003 Oct; 307(1):129-37. PubMed ID: 12954810
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
[TBL] [Abstract][Full Text] [Related]
7. Seizures increase importin-beta1 expression in NG2+ cells in the rat hippocampus.
Brilli E; Scali M; Casarosa S; Köhler M; Bozzi Y
J Neurosci Res; 2009 Feb; 87(3):636-43. PubMed ID: 18816794
[TBL] [Abstract][Full Text] [Related]
8. Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Dudra-Jastrzebska M; Andres-Mach M; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):18-25. PubMed ID: 19751793
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus.
Guggenhuber S; Alpar A; Chen R; Schmitz N; Wickert M; Mattheus T; Harasta AE; Purrio M; Kaiser N; Elphick MR; Monory K; Kilb W; Luhmann HJ; Harkany T; Lutz B; Klugmann M
Brain Struct Funct; 2016 May; 221(4):2061-74. PubMed ID: 25772509
[TBL] [Abstract][Full Text] [Related]
10. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
De Vry J; Denzer D; Reissmueller E; Eijckenboom M; Heil M; Meier H; Mauler F
J Pharmacol Exp Ther; 2004 Aug; 310(2):620-32. PubMed ID: 15140913
[TBL] [Abstract][Full Text] [Related]
11. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration.
Sim-Selley LJ; Schechter NS; Rorrer WK; Dalton GD; Hernandez J; Martin BR; Selley DE
Mol Pharmacol; 2006 Sep; 70(3):986-96. PubMed ID: 16760363
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats.
Huizenga MN; Wicker E; Beck VC; Forcelli PA
Epilepsia; 2017 Sep; 58(9):1593-1602. PubMed ID: 28691158
[TBL] [Abstract][Full Text] [Related]
13. CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery.
Hong J; Nandiwada V; Jones V; Lu M; Warner DS; Mukhopadhyay S; Sheng H
Neurosci Lett; 2015 Jun; 597():19-24. PubMed ID: 25881484
[TBL] [Abstract][Full Text] [Related]
14. Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus.
Steindel F; Lerner R; Häring M; Ruehle S; Marsicano G; Lutz B; Monory K
J Neurochem; 2013 Mar; 124(6):795-807. PubMed ID: 23289830
[TBL] [Abstract][Full Text] [Related]
15. Kainic acid-induced seizure activity alters the mRNA expression and G-protein activation of the opioid/nociceptin receptors in the rat brain cortex.
Turunc Bayrakdar E; Bojnik E; Armagan G; Kanit L; Benyhe S; Borsodi A; Yalcin A
Epilepsy Res; 2013 Jul; 105(1-2):13-9. PubMed ID: 23337899
[TBL] [Abstract][Full Text] [Related]
16. Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting.
Fezza F; Marrone MC; Avvisati R; Di Tommaso M; Lanuti M; Rapino C; Mercuri NB; Maccarrone M; Marinelli S
Mol Cell Neurosci; 2014 Sep; 62():1-9. PubMed ID: 25064144
[TBL] [Abstract][Full Text] [Related]
17. Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors.
Hohmann J; Rédei D; Forgo P; Szabó P; Freund TF; Haller J; Bojnik E; Benyhe S
Phytochemistry; 2011 Oct; 72(14-15):1848-53. PubMed ID: 21764086
[TBL] [Abstract][Full Text] [Related]
18. AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity.
Guggenhuber S; Monory K; Lutz B; Klugmann M
PLoS One; 2010 Dec; 5(12):e15707. PubMed ID: 21203567
[TBL] [Abstract][Full Text] [Related]
19. [Endogenous cannabinoid system in the brain: role in regulation of seizure activity].
Shubina LV; Kichigina VF
Usp Fiziol Nauk; 2012; 43(3):21-37. PubMed ID: 23101377
[TBL] [Abstract][Full Text] [Related]
20. Activation of G-proteins in brain by endogenous and exogenous cannabinoids.
Childers SR
AAPS J; 2006 Mar; 8(1):E112-7. PubMed ID: 16584117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
